Labcorp

New York – September 16, 2026 -- Qualcomm and Amazon unveiled a multi-generational product collaboration to build next-generation AI data center infrastructure, combining Amazon's cloud-scale compute with Qualcomm's power-efficient silicon design.

Qualcomm and Amazon target AI data center bottlenecks

The partnership addresses surging demand for compute, storage, networking and memory bandwidth as AI workloads scale exponentially, pairing Amazon's infrastructure with Qualcomm Technologies' system-level integration expertise.

Labcorp acquires MLM Medical Labs to expand clinical trial network

Labcorp's acquisition of MLM Medical Labs extends its central laboratory footprint, making it the only central lab provider with a wholly owned network spanning North America, Europe, Asia and Africa for biomarker and clinical trial services.

Burlington, N.C. – September 15, 2026 -- Labcorp (NYSE: LH) reaffirmed its full-year 2026 guidance and unveiled a long-term outlook through 2029 projecting compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share growth of 8.5% to 11.5%, the company said at its 2026 Investor Day.

Labcorp projects adjusted operating margin expansion of 75 to 150 basis points by 2029

The diagnostics and drug development laboratory company also targets compound annual free cash flow growth in line with adjusted earnings growth through the same period. Guidance assumes foreign exchange rates effective as of June 30, 2026, and reflects anticipated capital allocation including acquisitions, share repurchases and dividends.

Burlington, N.C. – September 11, 2026 -- Labcorp (NYSE: LH) has acquired MLM Medical Labs, a central and specialty laboratory provider with operations in the United States, Germany and South Africa, financial terms undisclosed.

Labcorp becomes the only central lab provider with wholly owned facilities on four continents

The deal extends Labcorp's laboratory footprint across North America, Europe, Asia and Africa, combining its global scale with MLM's regional laboratory network and biomarker testing capabilities. The transaction strengthens Labcorp's position as an independent central laboratory services provider for clinical trial sponsors.